Competitor News, Product Updates

MMIT Announces Game-Changing Solution for Life Sciences Companies

Patient Access Analytics solution combines coverage and claims data to provide a unique view of payer and prescriber behavior—offering instant answers using real-world data—to help patients access lifesaving treatments faster February 17, 2022 07:00 ET | Source: Managed Markets Insight & Technology, LLC Yardley, PA, Feb. 17, 2022 (GLOBE NEWSWIRE) — Following…

Competitor News

4 things Truveta has accomplished in 1 year

COVID-19 insights, increased funding, advancing patient care and creating new partnerships are just some of the first-year accomplishments achieved by Truveta, a comprehensive, de-identified data platform. Becker’s spoke with Truveta CEO Terry Myerson on what the company has learned, accomplished and is moving toward since its launch. First-year accomplishments During its…

Collaborations, Competitor News, Product Updates

Akute Health Partners with Health Gorilla to Unlock Nationwide Lab Ordering Capabilities

Palo Alto, California, Feb. 16, 2022 (GLOBE NEWSWIRE) — Health Gorilla, the leading Health Information Network in the United States, and Akute Health, a cutting-edge EHR transforming how patients and physicians interact with health records, announce a strategic partnership to expand Akute Health’s lab and diagnostic ordering capabilities.  Akute Health is creating…

Clinical Trials, Collaborations, Competitor News, Product Updates

THREAD and EVERSANA Announce Industry’s First Integrated, Decentralized Registry and Real-World Data (RWD)-Driven Evidence and Commercialization Solution

CHICAGO and CARY, N.C., Feb. 16, 2022 /PRNewswire/ — EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, and THREAD™, a leading technology and service provider enabling electronic clinical outcome assessments (eCOAs) and decentralized clinical trials (DCTs), today announced a new combined offering to give pharmaceutical companies a comprehensive and simultaneous…

Competitor News, Government/Regulatory, Oncology, Product Updates

Foundation Medicine’s ctDNA Monitoring Assay, FoundationOne®Tracker, Granted Breakthrough Device Designation by U.S. Food and Drug Administration

February 15, 2022 06:56 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device designation for its circulating tumor DNA (ctDNA) detection and molecular monitoring assay, FoundationOne®Tracker. The assay…

Collaborations, Competitor News, Data Partnership

Generating real-world data from health records: design of a patient-centric study in multiple sclerosis using a commercial health records platform

ABSTRACT OBJECTIVE: The FlywheelMS study will explore the use of a real-world health record data set generated by PicnicHealth, a patient-centric health records platform, to improve understanding of disease course and patterns of care for patients with multiple sclerosis (MS). MATERIALS AND METHODS: The FlywheelMS study aims to enroll 5000…

Clinical Trials, Competitor News, HR

Curebase Adds Two Clinical Trial Veterans to Kick-off New Advisory Board

SAN FRANCISCO, Feb. 14, 2022 /PRNewswire/ — Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board. The new board members will help the company develop technology, data, partnership and growth strategies designed to increase its share of the global decentralized clinical trial…